MANGALAM GLOBAL ENTERPRISE
Back to Income Statement
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,424 Cr | ₹1,279 Cr | ₹960 Cr | ₹582 Cr | ₹390 Cr |
What is the latest Revenue of MANGALAM GLOBAL ENTERPRISE ?
Year | Revenue |
---|---|
Mar2024 | ₹1,424 Cr |
Mar2023 | ₹1,279 Cr |
Mar2022 | ₹960 Cr |
Mar2021 | ₹582 Cr |
Mar2020 | ₹390 Cr |
How is Revenue of MANGALAM GLOBAL ENTERPRISE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,424 Cr | 11.36 | |
Mar2023 | ₹1,279 Cr | 33.24 | |
Mar2022 | ₹960 Cr | 64.99 | |
Mar2021 | ₹582 Cr | 49.24 | |
Mar2020 | ₹390 Cr | - |
Compare Revenue of peers of MANGALAM GLOBAL ENTERPRISE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM GLOBAL ENTERPRISE | ₹481.9 Cr | 3.5% | 11.2% | NA | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,264.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
INDO US BIOTECH | ₹307.9 Cr | 1.5% | 1.6% | -27% | Stock Analytics |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM GLOBAL ENTERPRISE | 3.5% |
11.2% |
|
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses